- Home
- Companies
- north america
- hemorrhage stroke
Show results for
Refine by
Hemorrhage Stroke Suppliers In North America
6 companies found
based inShanghai, CHINA
MicroPort is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives. All our solutions are designed to deliver on that belief. Our close ...
Immediate Occlusion, Effective Exclusion. Willis® Intracranial Stent Graft system is a stent graft solution for the treatment of intracranial aneurysms. The immediate blood flow reconstruction can effectively isolate the blood flow between the ...
based inIrvine, CALIFORNIA (USA)
We introduced one of the first neurovascular intervention devices in 1977. Now we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke as well as dedicated products to address peripheral embolization. We are ...
based inFremont, CALIFORNIA (USA)
Stryker's Neurovascular division strives to propel the field of stroke care through continuous, purposeful innovation that powers meaningful outcomes. Focused on advancing the practice of less invasive stroke therapies through its Complete Stroke ...
based inNew York,, NEW YORK (USA)
Established in early 2016, Aidoc is the leading provider of artificial intelligence solutions that support and enhance the impact of radiologist diagnostic power – helping them expedite patient treatment and improve quality of care. The company’s ...
Aidoc’s care coordination suite facilitates rapid triage and communication of patients with suspected stroke, alerting appropriately trained medical specialists and speeding access to lifesaving treatment. ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Z-VAD(OMe)-FMK (Z-Val-Ala-Asp(OMe)-FMK) is a cell-permeable and irreversible pan-caspase inhibitor[1]. Z-VAD(OMe)-FMK is an ubiquitin carboxy-terminal hydrolase L1 (UCHL1) inhibitor. Z-VAD(OMe)-FMK irreversibly modifies UCHL1 by targeting the active ...
based inBoston, MASSACHUSETTS (USA)
CervoMed is a clinical stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as ...
Our lead product candidate, Trans sodium crocetinate (TSC), is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and ...